ECM
Everence Capital Management Portfolio holdings
AUM
$1.55B
This Quarter Return
+1.07%
1 Year Return
+22.02%
3 Year Return
+82.69%
5 Year Return
+144.46%
10 Year Return
+389.74%
AUM
$1.22B
AUM Growth
+$1.22B
(+0.19%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
31.45%
Holding
783
New
58
Increased
87
Reduced
58
Closed
52
Top Buys
| 1 |
NVIDIA
NVDA
|
$9.51M |
| 2 |
Moderna
MRNA
|
$1.68M |
| 3 |
Cisco
CSCO
|
$1.26M |
| 4 |
Organon & Co
OGN
|
$1.24M |
| 5 |
Lincoln National
LNC
|
$1.11M |
Top Sells
| 1 |
CVS Health
CVS
|
$2.31M |
| 2 |
GameStop
GME
|
$1.83M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.3M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$1.1M |
| 5 |
Ecolab
ECL
|
$1.06M |
Sector Composition
| 1 | Technology | 20.14% |
| 2 | Financials | 11.49% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 9.31% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Fidelity National Information Services
FIS
$36.5B
| $2.05M | 0.17% | 16,860 -4,440 | -21% | -$540K |
|
102
Fiserv
FI
$75.1B
| $2.02M | 0.17% | 18,626 | – | – |
|
103
Aflac
AFL
$57.2B
| $1.99M | 0.16% | 38,140 +17,870 | +88% | +$931K |
|
104
Baker Hughes
BKR
$44.8B
| $1.98M | 0.16% | 80,150 | – | – |
|
105
Bank of New York Mellon
BK
$74.5B
| $1.97M | 0.16% | 38,024 +12,240 | +47% | +$634K |
|
106
Southern Company
SO
$102B
| $1.96M | 0.16% | 31,681 | – | – |
|
107
Capital One
COF
$145B
| $1.95M | 0.16% | 12,040 | – | – |
|
108
Consolidated Edison
ED
$35.4B
| $1.93M | 0.16% | 26,561 +5,310 | +25% | +$385K |
|
109
Sempra
SRE
$53.9B
| $1.9M | 0.16% | 15,043 +6,060 | +67% | +$767K |
|
110
Crown Castle
CCI
$43.2B
| $1.88M | 0.15% | 10,859 | – | – |
|
111
Roper Technologies
ROP
$56.6B
| $1.88M | 0.15% | 4,219 | – | – |
|
112
McKesson
MCK
$85.4B
| $1.81M | 0.15% | 9,084 | – | – |
|
113
Cadence Design Systems
CDNS
$95.5B
| $1.79M | 0.15% | 11,834 | – | – |
|
114
Analog Devices
ADI
$124B
| $1.79M | 0.15% | 10,694 +2,160 | +25% | +$362K |
|
115
Air Products & Chemicals
APD
$65.5B
| $1.78M | 0.15% | 6,945 -3,550 | -34% | -$909K |
|
116
Progressive
PGR
$145B
| $1.78M | 0.15% | 19,668 +4,260 | +28% | +$385K |
|
117
CME Group
CME
$96B
| $1.78M | 0.15% | 9,190 | – | – |
|
118
Sherwin-Williams
SHW
$91.2B
| $1.78M | 0.15% | 6,351 | – | – |
|
119
Becton Dickinson
BDX
$55.3B
| $1.75M | 0.14% | 7,110 | – | – |
|
120
Cigna
CI
$80.3B
| $1.75M | 0.14% | 8,722 +620 | +8% | +$124K |
|
121
Travelers Companies
TRV
$61.1B
| $1.73M | 0.14% | 11,393 +10 | +0.1% | +$1.52K |
|
122
Trane Technologies
TT
$92.5B
| $1.71M | 0.14% | 9,920 | – | – |
|
123
Xylem
XYL
$34.5B
| $1.68M | 0.14% | 13,610 | – | – |
|
|
124
Moderna
MRNA
$9.37B
| $1.68M | 0.14% | +4,370 | New | +$1.68M |
|
125
Hartford Financial Services
HIG
$37.2B
| $1.68M | 0.14% | 23,910 | – | – |
|